Which companies got promoted — or demoted — in their slots at #JPM18?

first_img Which companies got promoted — or demoted — in their slots at #JPM18? Log In | Learn More By Rebecca Robbins Jan. 7, 2018 Reprints Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+. First 30 days free. GET STARTED What’s included? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. GET STARTED What is it? SAN FRANCISCO — At the J.P. Morgan Healthcare Conference, as in life, scheduling is everything.Several hundred biopharma companies scored an invitation to give a corporate presentation during this week’s industry confab — but they won’t all have an equal chance to win over investors. Some will be presenting in more glamorous rooms, with more room to fit more investors, on a day more likely to draw an energized crowd. Business Dom Smith/STAT Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. Tags financejpm18STAT+last_img read more